GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gelesis Holdings Inc (OTCPK:GLSWQ) » Definitions » Beneish M-Score

GLSWQ (Gelesis Holdings) Beneish M-Score : -4.87 (As of Sep. 24, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Gelesis Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.87 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Gelesis Holdings's Beneish M-Score or its related term are showing as below:

GLSWQ' s Beneish M-Score Range Over the Past 10 Years
Min: -5.95   Med: -5.41   Max: -4.87
Current: -4.87

During the past 2 years, the highest Beneish M-Score of Gelesis Holdings was -4.87. The lowest was -5.95. And the median was -5.41.


Gelesis Holdings Beneish M-Score Historical Data

The historical data trend for Gelesis Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gelesis Holdings Beneish M-Score Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
Beneish M-Score
- -

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -5.95 -4.87

Competitive Comparison of Gelesis Holdings's Beneish M-Score

For the Biotechnology subindustry, Gelesis Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gelesis Holdings's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gelesis Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Gelesis Holdings's Beneish M-Score falls into.



Gelesis Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Gelesis Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2506+0.528 * -0.5478+0.404 * 0.982+0.892 * 0.5421+0.115 * 0.6734
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7156+4.679 * -0.252464-0.327 * 1.6684
=-4.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun23) TTM:Last Year (Jun22) TTM:
Total Receivables was $9.56 Mil.
Revenue was 1.107 + 1.753 + 2.628 + 6.652 = $12.14 Mil.
Gross Profit was 0.609 + 0.516 + -11.615 + 3.036 = $-7.45 Mil.
Total Current Assets was $24.68 Mil.
Total Assets was $95.88 Mil.
Property, Plant and Equipment(Net PPE) was $58.13 Mil.
Depreciation, Depletion and Amortization(DDA) was $7.56 Mil.
Selling, General, & Admin. Expense(SGA) was $44.72 Mil.
Total Current Liabilities was $50.24 Mil.
Long-Term Debt & Capital Lease Obligation was $27.96 Mil.
Net Income was -7.681 + -5.246 + -24.51 + -14.229 = $-51.67 Mil.
Non Operating Income was 2.88 + 7.736 + 4.015 + 3.943 = $18.57 Mil.
Cash Flow from Operations was 0.617 + -8.696 + -16.275 + -21.681 = $-46.04 Mil.
Total Receivables was $14.11 Mil.
Revenue was 8.973 + 7.514 + 2.892 + 3.014 = $22.39 Mil.
Gross Profit was 4.187 + 2.601 + 0.493 + 0.251 = $7.53 Mil.
Total Current Assets was $61.65 Mil.
Total Assets was $138.97 Mil.
Property, Plant and Equipment(Net PPE) was $58.03 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.87 Mil.
Selling, General, & Admin. Expense(SGA) was $115.28 Mil.
Total Current Liabilities was $36.71 Mil.
Long-Term Debt & Capital Lease Obligation was $31.24 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(9.564 / 12.14) / (14.106 / 22.393)
=0.787809 / 0.629929
=1.2506

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(7.532 / 22.393) / (-7.454 / 12.14)
=0.336355 / -0.614003
=-0.5478

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (24.678 + 58.129) / 95.875) / (1 - (61.651 + 58.03) / 138.969)
=0.136302 / 0.138794
=0.982

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=12.14 / 22.393
=0.5421

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4.873 / (4.873 + 58.03)) / (7.557 / (7.557 + 58.129))
=0.077468 / 0.115047
=0.6734

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(44.722 / 12.14) / (115.28 / 22.393)
=3.683855 / 5.148037
=0.7156

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((27.963 + 50.241) / 95.875) / ((31.237 + 36.707) / 138.969)
=0.815687 / 0.488915
=1.6684

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-51.666 - 18.574 - -46.035) / 95.875
=-0.252464

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Gelesis Holdings has a M-score of -4.87 suggests that the company is unlikely to be a manipulator.


Gelesis Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Gelesis Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Gelesis Holdings Business Description

Traded in Other Exchanges
N/A
Address
501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.

Gelesis Holdings Headlines

From GuruFocus

Gelesis to Report First Quarter 2022 Financial Results on May 12, 2022

By Business Wire Business Wire 05-09-2022